Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Dermatology|December 14, 2022
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire studyKeiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, et al.
The Journal of Dermatology|November 30, 2023
Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart reviewYayoi Tada, Mayumi Komine, Yukari Okubo, et al.
Current Medical Research and Opinion|April 26, 2021
Evaluation of treatment satisfaction misalignment between Japanese psoriasis patients and their physicians - Japanese psoriasis patients and their physicians do not share the same treatment satisfaction levelsYukari Okubo, Hitoe Torisu-Itakura, Takao Hanada, et al.
The Journal of Dermatological Treatment|June 29, 2019
Patient and physician preferences for atopic dermatitis injection treatments in JapanYukari Okubo, Kerrie-Anne Ho, Simon Fifer, et al.
European Journal of Pharmacology|December 11, 2008
Suppressive efficacy of roxithromycin against human peripheral-blood mononuclear cells stimulated with hemolytic streptococci superantigenSho Kamogawa, Keisuke Kagami, Masaki Maeda, et al.
Molecular Medicine Reports|October 18, 2017
Inhibitory effects of ubiquitination of synoviolin by PADI4Satoko Aratani, Hidetoshi Fujita, Naoko Yagishita, et al.
American Journal of Clinical Dermatology|July 2, 2024
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical TrialYukari Okubo, Satomi Kobayashi, Masamoto Murakami, et al.
Arerugi = [Allergy]|September 20, 2023
[TWO CASES OF ALLERGY WITH MUNG BEAN SPROUTS]Tomoko Kobayashi, Tomonobu Ito, Harutaka Seshimo, et al.
Experimental Dermatology|September 15, 2024
Psoriasiform drug eruption: A case series with a review of the literatureMiho Mori, Hiroshi Kawakami, Rie Tobita, et al.
Experimental Dermatology|December 2, 2022
Topical application of imatinib mesylate suppresses vitamin D3 analog-induced dermatitis in Balb/c miceHarutaka Seshimo, Chizu Egusa, Tatsuo Maeda, et al.
Pageof 12